Clinical Medicine Insights-Endocrinology and Diabetes

Scope & Guideline

Exploring the forefront of endocrine and diabetes care.

Introduction

Welcome to your portal for understanding Clinical Medicine Insights-Endocrinology and Diabetes, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN1179-5514
PublisherSAGE PUBLICATIONS LTD
Support Open AccessYes
CountryUnited Kingdom
TypeJournal
Convergefrom 2009 to 2024
AbbreviationCLIN MED INSIGHTS-EN / Clin. Med. Insights-Endocrinol. Diabetes
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND

Aims and Scopes

The journal 'Clinical Medicine Insights-Endocrinology and Diabetes' focuses on the multifaceted aspects of endocrine disorders and diabetes, emphasizing clinical research, innovative therapies, and the integration of technology in treatment protocols. It aims to bridge the gap between clinical practice and research, providing a platform for the dissemination of knowledge that can enhance patient care and outcomes.
  1. Endocrine Disorders Research:
    The journal publishes studies related to various endocrine disorders, including thyroid diseases, adrenal dysfunctions, and metabolic syndromes, with an emphasis on understanding their pathophysiology and clinical implications.
  2. Diabetes Management and Treatment Innovations:
    A significant focus is placed on the latest advancements in diabetes management, including pharmacological interventions, lifestyle modifications, and technological innovations such as digital health tools.
  3. Clinical Trials and Meta-Analyses:
    The journal features systematic reviews and meta-analyses that synthesize evidence from clinical trials, providing insights into the efficacy and safety of treatments for endocrine and metabolic disorders.
  4. Socio-Cultural Aspects of Diabetes Care:
    Research that explores the impact of socio-cultural factors on diabetes management and health outcomes is highlighted, recognizing the importance of culturally sensitive approaches in patient care.
  5. Emerging Biomarkers and Diagnostic Tools:
    The publication emphasizes the identification and validation of new biomarkers for early diagnosis and monitoring of endocrine and metabolic conditions, leveraging advanced technologies such as LC-MS/MS.
The journal has recently seen an increase in publications addressing contemporary issues and innovative solutions in endocrinology and diabetes, reflecting the evolving landscape of research and clinical practice.
  1. Digital Health Interventions:
    There is a growing emphasis on the role of digital health technologies in diabetes prevention and management, highlighting the importance of telehealth, mobile apps, and wearable devices in improving patient outcomes.
  2. Mental Health and Diabetes:
    Recent publications have increasingly addressed the intersection of mental health and diabetes, recognizing the psychological impact of chronic disease management and the need for integrated care approaches.
  3. Diabetes and COVID-19 Research:
    The impact of COVID-19 on diabetes management and the risk of severe outcomes in diabetic patients has become a significant theme, reflecting the pandemic's influence on clinical practice and research priorities.
  4. Cultural Competence in Diabetes Care:
    Emerging studies focusing on culturally sensitive diabetes management strategies are on the rise, underscoring the importance of tailoring interventions to diverse patient populations.
  5. Innovative Biomarkers for Disease Monitoring:
    There is an increased focus on the discovery and validation of novel biomarkers for metabolic diseases, which may enhance early diagnosis and personalized treatment strategies.

Declining or Waning

While the journal continues to cover a broad spectrum of topics in endocrinology and diabetes, certain themes have shown a decline in frequency, reflecting shifts in research focus and emerging priorities in the field.
  1. Historical Perspectives on Diabetes:
    Papers that explore historical approaches and treatments for diabetes have become less prominent, as the focus shifts towards contemporary evidence-based practices and innovations.
  2. Traditional Pharmacological Approaches:
    There has been a noticeable decrease in studies centered on older, less effective diabetes medications, as newer therapies gain prominence and researchers focus more on novel agents and combination therapies.
  3. Single-Centric Studies:
    Research that is limited to single-center studies is waning, with a growing preference for multi-center trials that provide more generalizable results and broader insights into treatment efficacy.
  4. Generalized Epidemiological Studies:
    There is a diminishing focus on broad epidemiological studies without specific interventions or outcomes, as the journal increasingly emphasizes studies that link findings to clinical practice and patient management.
  5. Basic Science without Clinical Relevance:
    Basic science research that does not translate into clinical applications or implications for patient care is appearing less frequently, as the journal aims to prioritize studies with direct relevance to clinical practice.

Similar Journals

Practical Diabetes

Enhancing patient outcomes through cutting-edge diabetes research.
Publisher: JOHN WILEY & SONS LTDISSN: 2047-2897Frequency: 9 issues/year

Practical Diabetes is an esteemed journal dedicated to advancing the understanding and management of diabetes and related metabolic disorders. Published by John Wiley & Sons Ltd, this journal serves as a vital resource for healthcare professionals, researchers, and students seeking to explore the latest findings and practical applications in the field of endocrinology. With an ISSN of 2047-2897, it has established itself as a respected outlet for impactful research since its inception in 2011, with a convergence period extending until 2024. Although currently listed in Q4 for Endocrinology, Diabetes, and Metabolism and Q3 for Internal Medicine, the journal is committed to improving its rank and increasing its relevance in a competitive academic landscape. While not an open-access publication, Practical Diabetes provides valuable insights and evidence-based practices that are crucial for improving patient outcomes. Researchers and practitioners alike will find a wealth of knowledge to inform their work and enhance their understanding of diabetes management, making this journal an essential addition to any academic library collection.

METABOLISM-CLINICAL AND EXPERIMENTAL

Elevating Knowledge in Biochemistry and Metabolism
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 0026-0495Frequency: 12 issues/year

METABOLISM-CLINICAL AND EXPERIMENTAL is a premier academic journal published by W B SAUNDERS CO-ELSEVIER INC, with a distinguished history dating back to 1952. This journal serves as a vital repository of knowledge in the fields of Endocrinology, Diabetes, and Metabolism, consistently ranking in the top quartile (Q1) within these categories according to the latest metrics. With an impressive impact factor and recognized for its contributions to Biochemistry, Genetics, and Molecular Biology, it ranks #5 out of 128 in the Scopus database for Endocrinology and #11 out of 244 for Medicine related to Endocrinology, Diabetes, and Metabolism, placing it in the 95th and 96th percentiles, respectively. While the journal does not currently offer open access, it maintains rigorous peer review standards and publishes cutting-edge research that drives forward the understanding of metabolic diseases and clinical practices. By engaging with METABOLISM-CLINICAL AND EXPERIMENTAL, researchers, healthcare professionals, and students can explore groundbreaking advancements and pivotal findings that shape the future of metabolic health.

JOURNAL OF ENDOCRINOLOGY

Transforming Knowledge into Practice in Endocrinology
Publisher: BIOSCIENTIFICA LTDISSN: 0022-0795Frequency: 12 issues/year

JOURNAL OF ENDOCRINOLOGY, established in 1946 and published by BIOSCIENTIFICA LTD, stands as a premier scholarly outlet in the field of endocrinology, diabetes, and metabolism. With an impressive H-Index reflecting its significant contribution to the literature, this journal maintains a strong presence in academic circles, evidenced by its Q1 ranking in the 2023 Scopus categories for both Endocrinology and Diabetes and Metabolism. With its targeted scope serving a global audience of researchers, professionals, and students, it provides a vital platform for disseminating innovative research findings and advancing the scientific understanding of endocrine systems. As we approach its convergence year of 2024, JOURNAL OF ENDOCRINOLOGY remains committed to publishing high-quality, peer-reviewed articles that explore cutting-edge developments in the field, thereby impacting clinical practices and guiding future research directions.

Journal of Endocrinology and Metabolism

Fostering dialogue on critical issues in endocrinology and metabolism.
Publisher: ELMER PRESS INCISSN: 1923-2861Frequency: 4 issues/year

Journal of Endocrinology and Metabolism is a dynamic and essential publication in the field of endocrinology, diabetes, and metabolism, published by ELMER PRESS INC in Canada. With an ISSN of 1923-2861 and E-ISSN 1923-287X, this journal serves as a pivotal platform for sharing innovative research and advancements from 2018 through 2024. Although categorized in the fourth quartile (Q4) for 2023, its commitment to high-quality research is reflected in its ongoing efforts to foster scholarly dialogue and illuminate critical issues within its scope. Targeting primarily researchers, healthcare professionals, and students, the journal aims to disseminate crucial findings that advance our understanding of endocrine functions and metabolic processes. Given its Scopus ranking of #207 out of 244 within its category, the Journal of Endocrinology and Metabolism continues to contribute to the global discourse on these vital health topics.

Journal of the ASEAN Federation of Endocrine Societies

Leading the Charge: Advances in Endocrine Knowledge and Practice
Publisher: ASEAN FEDERATION ENDOCRINE SOCISSN: 0857-1074Frequency: 2 issues/year

Welcome to the Journal of the ASEAN Federation of Endocrine Societies, a pioneering publication dedicated to advancing knowledge and research in the fields of Endocrinology, Diabetes, and Metabolism. Established by the ASEAN Federation Endocrine Society and open access since 2011, this journal enhances the dissemination of critical findings and encourages collaboration among professionals and researchers across Southeast Asia and beyond. With an ISSN of 0857-1074 and E-ISSN of 2308-118X, the journal is indexed within Quartile 4 in the 2023 rankings of its categories, reflecting its commitment to providing a platform for scholarly work despite its emerging status. Situated in the Philippines, the journal focuses on the latest trends, treatments, and innovative research approaches in endocrinology, making it an essential resource for academics, clinicians, and students alike. We invite you to explore our content and contribute to advancing the endocrine sciences.

Diabetologie und Stoffwechsel

Connecting Researchers and Practitioners in Diabetes Care
Publisher: GEORG THIEME VERLAG KGISSN: 1861-9002Frequency: 6 issues/year

Diabetologie und Stoffwechsel is a prominent academic journal specializing in the fields of endocrinology, diabetes, and metabolism, published by GEORG THIEME VERLAG KG. Since its inception in 2006, this German journal has strived to disseminate cutting-edge research and innovative findings that advance the understanding of metabolic disorders and the management of diabetes. With an ISSN of 1861-9002 and an E-ISSN of 1861-9010, it caters to a diverse audience ranging from researchers to healthcare professionals and students in the medical field. While it currently holds a Q4 ranking in the 2023 Scopus quartiles for its area, the journal serves as a critical platform for emerging insights and discussions impacting diabetes care and research, fostering collaboration and knowledge-sharing in a rapidly evolving landscape. The convergence of its coverage until 2024 signifies a commitment to ongoing exploration into the complexities of metabolic health, making it a valuable resource for anyone passionate about these vital areas of health.

Acta Endocrinologica-Bucharest

Exploring the frontiers of endocrine research.
Publisher: EDITURA ACAD ROMANEISSN: 1841-0987Frequency: 4 issues/year

Acta Endocrinologica-Bucharest is a vital resource for those engaged in the study and practice of endocrinology, diabetes, and metabolic research. Published by EDITURA ACAD ROMANE, this journal emphasizes the dissemination of high-quality research and insights specific to the fields of endocrinology and autonomic systems. Although categorized in the lower quartiles of its subject areas according to the latest rankings—Q4 in Endocrine and Autonomic Systems and Q4 in Endocrinology—it serves as an important platform for emerging scientific ideas and collaborative studies within the endocrinology community. With an ISSN of 1841-0987 and an E-ISSN of 1843-066X, the journal provides a significant opportunity for authors to contribute to the growing body of knowledge in these fields from its base in Romania. Researchers and practitioners alike will find valuable contributions that reflect both contemporary challenges and advances in endocrinology, reinforcing the journal's commitment to enhancing scholarly communication.

Lancet Diabetes & Endocrinology

Exploring the frontiers of metabolic health.
Publisher: ELSEVIER SCIENCE INCISSN: 2213-8587Frequency: 12 issues/year

Lancet Diabetes & Endocrinology is a premier peer-reviewed journal, published by Elsevier Science Inc, dedicated to advancing the fields of endocrinology, diabetes, and metabolism. Established in 2013, this journal has quickly ascended to a position of notable prestige, reflected in its prestigious Q1 rank across various categories, including Endocrinology, Internal Medicine, and Diabetes & Metabolism. With an impressive impact factor and Scopus rankings placing it in the 99th percentile of its field, it serves as a vital resource for researchers, healthcare professionals, and students alike. The journal aims to disseminate high-quality research covering clinical and experimental aspects of metabolic and endocrine disorders, making it an indispensable tool for those looking to stay at the forefront of these rapidly evolving fields. With its focus on innovative depth and cutting-edge studies, Lancet Diabetes & Endocrinology continually fosters an international dialogue critical for advancements in diabetes and endocrinology.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Elevating Clinical Standards Through Rigorous Research
Publisher: ENDOCRINE SOCISSN: 0021-972XFrequency: 12 issues/year

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, published by the Endocrine Society, stands as a premier academic journal within the field of endocrinology, diabetes, and metabolism. With a legacy spanning from 1941 to 2024, this journal is distinguished by its significant impact factor, ranking in the Q1 category across multiple related disciplines including biochemistry, clinical biochemistry, and medicine. This esteemed journal, ISSN 0021-972X and E-ISSN 1945-7197, is backed by rigorous peer review, ensuring the publication of high-quality research that contributes to the advancement of clinical practices and scientific knowledge. With a commendable Scopus ranking, positioned in the top percentile of multiple categories, JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM serves as an essential resource for researchers, professionals, and students who seek to stay informed about the latest findings and innovations in endocrine research. The journal enriches the existing body of knowledge and fosters discussion among scholars and practitioners alike, solidifying its crucial role in the ongoing discourse in endocrinology and metabolic health.

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

Advancing Knowledge in Endocrinology and Diabetes
Publisher: GEORG THIEME VERLAG KGISSN: 0947-7349Frequency: 10 issues/year

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES is a distinguished journal published by GEORG THIEME VERLAG KG, dedicated to advancing research and understanding in the fields of endocrinology, diabetes, and metabolism. With an ISSN of 0947-7349 and an E-ISSN of 1439-3646, this journal serves as a critical platform for disseminating high-quality research findings, reviews, and clinical studies from 1983 to 2024. The journal holds an impactful position within its respective categories, notably achieving Q3 in Endocrinology and Diabetes and Metabolism, and Q2 in Internal Medicine as per the 2023 category quartiles. Additionally, it ranks in the 57th and 46th percentiles in the Scopus rankings for Internal Medicine and Endocrinology, Diabetes and Metabolism, respectively. Though not an open-access publication, the journal caters to a global audience of researchers, professionals, and students, facilitating knowledge exchange and fostering collaboration within this vital area of medical science.